100
Participants
Start Date
September 2, 2017
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2026
HIPEC
Following complete cytoreductive surgery without any evidence of residual disease, the patient will be randomized either HIPEC (intervention) or no-HIPEC (control) in the operative Room. If the arm HIPEC is obtained, then a HIPEC procedure with cisplatin and doxorubicin will be performed. If no-HIPEC (control arm) is assigned then the surgical procedure will be finished.
RECRUITING
National Cancer Institute of Mexico, Mexico City
Instituto Nacional de Cancerologia de Mexico
OTHER